Health

Moonbuddy Kids Breathing Guidance Under Investigation: Tactile Breathwork Device Claims Get Reviewed

Farmers Branch, TX, April 20, 2026 (GLOBE NEWSWIRE) -- This content is intended as a general informational overview of Moonbuddy's…

2 months ago

TRT UK – What Is TRT and Who Should Take a TRT Test? A Complete UK Guide

Hampshire, England, April 21, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This content is provided for informational purposes only and does not…

2 months ago

Reminder: Last Exercise Day for Nicox June 2024 Warrants is June 19, 2026

Press Release Reminder: Last Exercise Day for Nicox June 2024 Warrants is June 19, 2026April 20, 2026 – release at…

2 months ago

Ascentage Pharma to Present Four Promising Preclinical Studies Demonstrating the Potential of Combination Therapies at American Association for Cancer Research (AACR) 2026 Annual Meeting

ROCKVILLE, Md. and SUZHOU, China, April 19, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a…

2 months ago

Sutro Biopharma Presents Promising Preclinical Data Across its Pipeline of Next-Generation Single and Dual-Payload ADC Programs at AACR 2026

April 19, 2026 19:45 ET  | Source: Sutro Biopharma, Inc. STRO-004 demonstrates robust and consistent antitumor activity across multiple TF-expressing…

2 months ago

Herz P1 Smart Oximeter Claims Evaluated: Best Pulse Oxygen Monitor Device on the Market with Clinical-Grade Accuracy

Akron, OH, April 18, 2026 (GLOBE NEWSWIRE) -- This article contains affiliate links. If a purchase is made through these…

2 months ago

Vigor Boost Gummies Claims Evaluated: The ForceVital Male Enhancement Formula Under Investigation

Largo, FL, April 18, 2026 (GLOBE NEWSWIRE) -- This release provides an informational summary of Vigor Boost Gummies based on…

2 months ago

SlimLeaf Claims Evaluated: The FitBurn Formula Using Slim Leaf Ingredients for Weight Loss

Largo, FL, April 18, 2026 (GLOBE NEWSWIRE) -- This report contains affiliate links. If a purchase is made through these…

2 months ago

Press Release: ESCMID: Sanofi’s Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study

ESCMID: Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study First head-to-head, double-blind, randomized phase 4 study…

2 months ago

VigoSurge Claims Evaluated: Analyzing the Ingredients’ Benefits, Side Effects Risk and Customer Complaints

Aurora, CO, April 18, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This release is for informational purposes only and does not constitute…

2 months ago